Assignee
MYREXIS INC
US·6 granted patents·5 pending applications·10 citations·filing 2002–2016
Top patents by PatentIndex Score
11 records- 0177US7989462B24-arylamin-or-4-heteroarylamino-quinazolines and analogs as activators of caspases and inducers of apoptosis and the use thereofMYREXIS INC·Filed 2007·Granted Aug 2, 2011·4 cites·26 claims
- 0275US7816099B1Enzyme assay and use thereofMYREXIS INC·Filed 2008·Granted Oct 19, 2010·1 cites·3 claims
- 0374US7799768B2Polymorphs of 3-O-(3′,3′-dimethylsuccinyl)betulinic acid di-N-methyl-D-glucamineMYREXIS INC·Filed 2006·Granted Sep 21, 2010·1 cites·28 claims
- 0471US7842805B2Pharmaceutical compounds as activators of caspases and inducers of apoptosis and the use thereofMYREXIS INC·Filed 2007·Granted Nov 30, 2010·2 cites·14 claims
- 0566US7943146B2Immunizing compositions comprising HIV-1 proviral constructs with an inactive p6 gag TSG101 UEV binding domain capable of producing budding-defective viral particles that remain tethered to the cell surfaceMYREXIS INC·Filed 2002·Granted May 17, 2011·2 cites·27 claims
- 0656US8017780B1Therapeutic compounds and uses thereofMYREXIS INC·Filed 2009·Granted Sep 13, 2011·0 cites·20 claims
- 0747US2013029942A1Compounds and therapeutical uses thereofMYREXIS INC·Filed 2012·Application pending·0 cites
- 0842US2011224240A1Methods of treating cancer and related diseasesMYREXIS INC·Filed 2011·Application pending·0 cites
- 0938US2013317027A1Compounds and therapeutic uses thereofMYREXIS INC·Filed 2012·Application pending·0 cites
- 1038US2011200619A1Pharmaceutical compounds as cytotoxic agents and uses thereofMYREXIS INC·Filed 2011·Application pending·0 cites
- 1136US2017096446A1Extended Triterpene DerivativesMYREXIS INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when MYREXIS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →